Nasdaq OMX Group and Carlyle Group Talked Buyout in January

Michael Teague |

Nasdaq OMX Group and Carlyle Talked Buyout in JanuaryNasdaq OMX Group (NDAQ) saw its stock jump significantly by mid-day (up 3.46 percent sending shares to their highest point since the crash of 2008), resulting from reports that it had been in talks with the Carlyle Group (CG) about a buyout.  The talks between the second largest stock-exchange operator in the world and the private equity group took place three weeks ago and reportedly faltered on a disagreement between the two over the value of NDAQ.

The last two years have seen a spate of attempts to buy out exchange companies, with this latest report coming less than a month after IntercontinentalExchange’s (ICE) $8.2 billion acquisition of NYSE Euronext (NYX).  The talks between Nasdaq and Carlyle likely hinged in part on the latter’s CFO Adeena Friedman who, before joining Carlyle in 2011 had been with Nasdaq in a variety of capacities since 1993.  Indeed, shortly after her arrival at Carlyle, the company went public on the Nasdaq.

With a general decline in trade revenues, Nasdaq has recently been attempting to cut expenses, as well as reorient itself towards more profitable products such as derivatives. After a stronger than expected 2012 fourth-quarter earnings report, however it is not clear if this has anything to do with NDAQ’s potential interest in going private.

Both companies have been very tight-lipped about the discussions. After Fox Business Network initially broke the news earlier today, nobody from either side of the talks has been willing to put their name on a statement, and has not said more than that the talks broke down around three weeks ago, after a difference of opinion regarding the overall worth of Nasdaq in the context of a buyout.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
CG The Carlyle Group L.P. 16.05 0.00 0.00 53
ICE Intercontinental Exchange Inc. 266.32 0.00 0.00 0
NDAQ Nasdaq Inc. 64.69 0.00 0.00 0
RNF Rentech Nitrogen Partners L.P. n/a n/a n/a 0


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.